Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Raphanus sativus, commonly known as radish, is a plant species belonging to the Brassicaceae family. It is recognized for its agricultural utility as a cover crop and intercrop, contributing to biomass production and soil health, and exhibiting biofumigant and allelopathic properties. Beyond its agricultural applications, Raphanus sativus is a rich source of diverse bioactive phytochemicals, including flavonoids, phenolic acids, anthocyanins, and glucosinolates. Research indicates its potential health benefits, such as gastroprotective effects, anti-obesity properties, and cognitive improvement, primarily through antioxidant and anti-inflammatory activities, and modulation of gut microbiota. It is also studied for its role in enhancing plant stress tolerance and mitigating heavy metal uptake in contaminated soils.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Raphanus sativus.